Learn More
Cayman Chemical KM 233 Neurochemicals

Supplier: Cayman Chemical 106401 MG
Δ8-THC analog with 13-fold selectivity for the CB2 receptor (Kis = 12.3 and 0.91 nM, for CB1 and CB2 respectively); its CB agonist activity inhibits human U87 glioma cell proliferation in vitro ( IC50 = 1.4 μM) and in vivo (2 mg/kg in a SCID mouse xenograft side-pocket model)
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.